A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
Clinical trial NCT04854668 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04854668
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2024-12-31
- Enrollment
- 748
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.